1. Home
  2. UNB vs PYPD Comparison

UNB vs PYPD Comparison

Compare UNB & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Union Bankshares Inc.

UNB

Union Bankshares Inc.

HOLD

Current Price

$23.26

Market Cap

105.4M

Sector

Finance

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.50

Market Cap

85.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNB
PYPD
Founded
1891
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
105.4M
85.1M
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
UNB
PYPD
Price
$23.26
$4.50
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$12.25
AVG Volume (30 Days)
20.2K
151.7K
Earning Date
04-15-2026
05-06-2026
Dividend Yield
5.76%
N/A
EPS Growth
25.52
N/A
EPS
0.65
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$35.46
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.65
$2.79
52 Week High
$29.49
$5.21

Technical Indicators

Market Signals
Indicator
UNB
PYPD
Relative Strength Index (RSI) 43.63 45.50
Support Level $23.06 $4.15
Resistance Level $24.77 $4.56
Average True Range (ATR) 0.53 0.28
MACD -0.04 -0.02
Stochastic Oscillator 23.19 1.41

Price Performance

Historical Comparison
UNB
PYPD

About UNB Union Bankshares Inc.

Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The Company has one definable business segment, Union Bank, which provides full retail, commercial, municipal banking, and wealth management and trust services throughout its 18 branch banking locations, three loan centers, and several ATMs covering northern Vermont and northern New Hampshire. In addition, it also offers fiduciary and asset management services through its Asset Management Group.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: